Viewing Study NCT00090116


Ignite Creation Date: 2025-12-26 @ 11:45 AM
Ignite Modification Date: 2026-03-06 @ 2:03 PM
Study NCT ID: NCT00090116
Status: COMPLETED
Last Update Posted: 2012-03-05
First Post: 2004-08-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: The Safety and Efficacy of Neramexane in Patients With Moderate to Severe Alzheimer's Disease
Sponsor: Forest Laboratories
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Alzheimer's Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Neramexane View
None NMDA receptor antagonist View
None Memory Loss View
None Alzheimer Disease View